Drug Effect: Clinical Trials

8 trials for Drug Effect, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 2, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Completed 8
Phase 13Completed 3
Phase 31Completed 1

Follow Drug Effect: new trials by email Literature Review of Drug Effect trials Research Report on Drug Effect

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Different Volumes of Articaine for Inferior Alveolar Nerve Block in Irreversible Pulpitis
Articaine HCl 4 % / EPINEPHrine 1:100,000 in 1.8 mL Dental Cartridge - Drug Effect, Pulpitis - Irreversible
Phase 2CompletedArmed Forces Institute of Dentistry, Pakistan782023-12-012024-10-15
Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients
Tacrolimus, Placebo (for Tacrolimus) - Aplastic Anemia, Drug Effect
Phase 2CompletedPeking Union Medical College Hospital1142020-07-012023-01-19
Ketamine to Improve Recovery After Cesarean Delivery - Part 1
Ketamine - Obstetric Pain, Postpartum Depression
Phase 2CompletedGrace Lim, MD, MS82019-10-092022-12-20
Evaluation of Antibacterial Effect of Allium Sativum, Calcium Hydroxide and Their Combination in Infected Mature Teeth
Allium Sativum, Polymerase chain reaction - Drug Effect
Phase 2 / Phase 3CompletedSuez Canal University482019-10-082021-09-20
Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis
Calcipotriol ointment, adipose-derived multipotent mesenchymal stem cells - Mesenchymal Stromal Cells, Psoriasis
Phase 1 / Phase 2CompletedGuangdong Provincial Hospital of Traditional Chinese Medicine82019-07-232023-08-24
Evaluation of Efficacy and Safety of Subcutaneous Acetaminophen
Acetaminophen - Pain, Fever
Phase 2CompletedSaint-Joseph University312018-05-172020-06-09
Effects of Salvinorin A on Brain Function
Salvinorin A - Drug Effect
Phase 1 / Phase 2CompletedJohns Hopkins University132017-12-142021-03-04
Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis
adipose-derived multipotent mesenchymal stem cells - Mesenchymal Stromal Cells, Psoriasis
Phase 1 / Phase 2CompletedGuangdong Provincial Hospital of Traditional Chinese Medicine72017-09-242023-08-25

Narrower conditions

Drug-Related Side Effects and Adverse Reactions (3)  ·  Psoriasis (2)  ·  Acute Pain (1)  ·  Anemia, Aplastic (1)  ·  Breast Feeding (1)  ·  Chronic Pain (1)  ·  Depression, Postpartum (1)  ·  Fever (1)  ·  Labor Pain (1)  ·  Pain (1)

Broader conditions

Chemically-Induced Disorders (3)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Papulosquamous (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Anemia (1)  ·  Behavior (1)  ·  Body Temperature Changes (1)  ·  Bone Marrow Diseases (1)  ·  Bone Marrow Failure Disorders (1)  ·  Depressive Disorder (1)  ·  Feeding Behavior (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)

Interventions

Acetaminophen (1)  ·  Calcium Hydroxide (1)  ·  Carticaine (1)  ·  Epinephrine (1)  ·  Ketamine (1)  ·  Polymerase Chain Reaction (1)  ·  Tacrolimus (1)  ·  salvinorin A (1)

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine (2)  ·  Armed Forces Institute of Dentistry, Pakistan (1)  ·  Grace Lim, MD, MS (1)  ·  Johns Hopkins University (1)  ·  Peking Union Medical College Hospital (1)  ·  Saint-Joseph University (1)  ·  Suez Canal University (1)

Countries

China (3)  ·  United States (2)  ·  Egypt (1)  ·  Lebanon (1)  ·  Pakistan (1)

Top investigators

Chuanjian Lu (1)  ·  Chuanjian Lu, PhD (1)  ·  Frederick S Barrett, Ph.D. (1)  ·  Grace Lim, MD, MS (1)  ·  Joe El Khoury, MD (1)  ·  Kanza Zafar, BDS (1)  ·  Shaimaa M. Mahfouz, PhD (1)

Results publications

PMID 34988162

NIH funding

R01DA003889 (1)